scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12640-009-9043-Z |
P698 | PubMed publication ID | 19384570 |
P2093 | author name string | Alexander Storch | |
Johannes Schwarz | |||
Sigrid C Schwarz | |||
Anatol Manaenko | |||
Javorina Milosevic | |||
Michael Arend | |||
Gail Walkinshaw | |||
Lee A Flippin | |||
Irena Adler | |||
P2860 | cites work | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | Q22009936 |
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing | Q24291102 | ||
A conserved family of prolyl-4-hydroxylases that modify HIF | Q24291794 | ||
Crosstalk between HIF-1 and ROCK pathways in neuronal differentiation of mesenchymal stem cells, neurospheres and in PC12 neurite outgrowth. | Q53554059 | ||
Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen | Q73011132 | ||
Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent | Q73337460 | ||
Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium | Q79842788 | ||
Oxygen tension regulates survival and fate of mouse central nervous system precursors at multiple levels | Q80447423 | ||
In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain | Q80718572 | ||
Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor | Q80783829 | ||
HIF-1: hypoxia-inducible factor or dysoxia-inducible factor? | Q83289607 | ||
Dopamine D2/D3 receptor stimulation fails to promote dopaminergic neurogenesis of murine and human midbrain-derived neural precursor cells in vitro | Q94560957 | ||
HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques | Q24684076 | ||
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation | Q27860876 | ||
HIF-1: mediator of physiological and pathophysiological responses to hypoxia | Q28140835 | ||
Lack of hypoxia-inducible factor-1 alpha impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling | Q28506157 | ||
Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo | Q28577046 | ||
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription | Q29614203 | ||
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry | Q29617253 | ||
Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia | Q33279493 | ||
A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. | Q34488111 | ||
Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport | Q35823379 | ||
Effects of hypoxia on the proliferation and differentiation of NSCs | Q36161865 | ||
Integration of oxygen signaling at the consensus HRE. | Q36290265 | ||
Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. | Q36372667 | ||
Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. | Q36542391 | ||
Developmental perspectives on human midbrain-derived neural stem cells | Q36565724 | ||
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system | Q36980763 | ||
Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia | Q37441879 | ||
Expansion of human SCID-repopulating cells under hypoxic conditions | Q39778145 | ||
Stage-dependent vulnerability of fetal mesencephalic neuroprogenitors towards dopaminergic neurotoxins | Q39976901 | ||
Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production | Q40176738 | ||
Neurorescue effects of VEGF on a rat model of Parkinson's disease | Q40393076 | ||
Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts | Q40572310 | ||
Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells | Q40789736 | ||
HEK-293 cells expressing the human dopamine transporter are susceptible to low concentrations of 1-methyl-4-phenylpyridine (MPP+) via impairment of energy metabolism | Q40923586 | ||
Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein | Q41337564 | ||
Novel "hybrid" iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cells | Q44045931 | ||
Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha | Q44329029 | ||
Cobalt induces hypoxia-inducible factor-1alpha expression in airway smooth muscle cells by a reactive oxygen species- and PI3K-dependent mechanism | Q44980707 | ||
Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin | Q46161591 | ||
Cobalt chloride induces neurite outgrowth in rat pheochromocytoma PC-12 cells through regulation of endothelin-2/vasoactive intestinal contractor | Q46538621 | ||
Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney | Q46564874 | ||
Increase in dopaminergic neurons from mouse embryonic stem cell-derived neural progenitor/stem cells is mediated by hypoxia inducible factor-1alpha | Q46625115 | ||
Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation | Q46626427 | ||
Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia | Q46628252 | ||
Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways | Q46738211 | ||
Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs | Q46838438 | ||
Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation | Q48119740 | ||
Erythropoietin is neuroprotective on GABAergic neurons against kainic acid-excitotoxicity in the rat spinal cell cultures | Q48172712 | ||
Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin | Q48269054 | ||
Uracil nucleotides stimulate human neural precursor cell proliferation and dopaminergic differentiation: involvement of MEK/ERK signalling | Q48382214 | ||
Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells | Q48497907 | ||
Low atmospheric oxygen avoids maturation, senescence and cell death of murine mesencephalic neural precursors | Q49088945 | ||
Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. | Q50640546 | ||
P433 | issue | 4 | |
P921 | main subject | hypoxia | Q105688 |
P304 | page(s) | 367-380 | |
P577 | publication date | 2009-03-20 | |
P1433 | published in | Neurotoxicity Research | Q15764278 |
P1476 | title | Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-alpha): relevance in neural progenitor/stem cells | |
P478 | volume | 15 |
Q45753972 | A role for prolyl hydroxylase domain proteins in hippocampal synaptic plasticity. |
Q33479532 | Characterization of voltage-gated potassium channels in human neural progenitor cells |
Q47229257 | Cobalt chloride compromises transepithelial barrier properties of CaCo-2 BBe human gastrointestinal epithelial cell layers |
Q38587566 | Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders. |
Q42738980 | Delayed hyperbaric oxygen therapy promotes neurogenesis through reactive oxygen species/hypoxia-inducible factor-1α/β-catenin pathway in middle cerebral artery occlusion rats |
Q34904038 | Differentiated neuroprogenitor cells incubated with human or canine adenovirus, or lentiviral vectors have distinct transcriptome profiles |
Q37482127 | Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model |
Q35188823 | Fluorescent protein-expressing neural progenitor cells as a tool for transplantation studies |
Q34124072 | Genome-wide expression profiling and functional network analysis upon neuroectodermal conversion of human mesenchymal stem cells suggest HIF-1 and miR-124a as important regulators |
Q92963227 | Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients - a retrospective analysis |
Q35595585 | Hyperbaric oxygen therapy promotes neurogenesis: where do we stand? |
Q41856276 | Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke |
Q48130155 | Manipulation of neural progenitor fate through the oxygen sensing pathway |
Q34978937 | Matrix metalloproteinase (MMP)-9 induced by Wnt signaling increases the proliferation and migration of embryonic neural stem cells at low O2 levels |
Q35382648 | Metabolic circuits in neural stem cells |
Q38287785 | Metabolic regulation of mesenchymal stem cell in expansion and therapeutic application |
Q26824421 | Oxygen levels and the regulation of cell adhesion in the nervous system: a control point for morphogenesis in development, disease and evolution? |
Q60959823 | Possible Role of PHD Inhibitors as Hypoxia-Mimicking Agents in the Maintenance of Neural Stem Cells' Self-Renewal Properties |
Q33722449 | Preclinical Analysis of Fetal Human Mesencephalic Neural Progenitor Cell Lines: Characterization and Safety In Vitro and In Vivo |
Q38577907 | Prolyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy |
Q34997944 | Stem cell therapy in neurodegenerative diseases: From principles to practice |
Q39639036 | The pacific chapter annual meeting of the undersea & hyperbaric medical society. |
Q35710695 | Transcriptional Response of Human Neurospheres to Helper-Dependent CAV-2 Vectors Involves the Modulation of DNA Damage Response, Microtubule and Centromere Gene Groups |
Q37783805 | Translation of stem cell therapy for neurological diseases |
Q24298202 | Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis |
Search more.